Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: Long-term follow-up
- 30 June 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (6) , 684-691
- https://doi.org/10.1016/0277-5379(91)90166-b
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Children fathered by men treated with chemotherapy for testicular cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- The late effects of cis-platinum on renal functionEuropean Journal of Cancer and Clinical Oncology, 1989
- Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumoursEuropean Journal of Cancer and Clinical Oncology, 1989
- Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumorsEuropean Journal of Cancer and Clinical Oncology, 1988
- The effect of cisplatin on renal function in patients with testicular tumoursClinical Radiology, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- The Role of Surgery in the Combined Management of Metastases from Malignant Teratomas of TestisBritish Journal of Urology, 1987
- Cis-diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary reportCancer Treatment Reviews, 1985
- Etoposide salvage therapy for refractory germ cell tumors: an updateCancer Treatment Reviews, 1982
- EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN MALIGNANT TERATOMAS AND CHORIOCARCINOMASThe Lancet, 1977